Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer

Gi‐Hoon Nam(Harvard University), In‐San Kim(Korea University)
Journal for ImmunoTherapy of Cancer
July 1, 2021
Cited by 74


Related Papers